P. Gopalakrishna

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

Claire Harrison, Alessandro M. Vannucchi, Haifa Kathrin Al‐Ali et al. · Leukemia · 2016 · 509 citations · Full text

Medicine, Hematology, Pharmacology +13

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Alessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian et al. · Haematologica · 2015 · 253 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy

Bruno Coudert, Tudor–Eliade Ciuleanu, K. Park et al. · Annals of Oncology · 2011 · 102 citations · Full text

Medicine, Oncology, Pharmacology +11

Piperine-Loaded In Situ Gel: Formulation, In Vitro Characterization, and Clinical Evaluation against Periodontitis

P. Gopalakrishna, Rajamma Abburu Jayaramu, Sateesha Shivally Boregowda et al. · Gels · 2023 · 24 citations · Full text

Dentistry, Periodontics, Periodontology +17

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer

Tony Mok, Sarayut Lucien Geater, Nicholas Iannotti et al. · Annals of Oncology · 2014 · 12 citations · Full text

Medicine, Oncology, Pharmacology +11